Johnson & Johnson [NYSE: JNJ] slipped around -0.94 points on Tuesday, while shares priced at $176.46 at the close of the session, down -0.53%.
Compared to the average trading volume of 8.41M shares, JNJ reached a trading volume of 7958283 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Johnson & Johnson [JNJ]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for JNJ shares is $178.70 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on JNJ stock is a recommendation set at 2.23. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Erste Group have made an estimate for Johnson & Johnson shares, keeping their opinion on the stock as Buy, with their previous recommendation back on July 23, 2025. The new note on the price target was released on May 13, 2025, representing the official price target for Johnson & Johnson stock. Previously, the target price had yet another raise to $166, while BofA Securities analysts kept a Neutral rating on JNJ stock.
The Price to Book ratio for the last quarter was 5.41, with the Price to Cash per share for the same quarter was set at 7.84. Price to Free Cash Flow for JNJ in the course of the last twelve months was 22.91 with Quick ratio for the last quarter at 0.76.
How has JNJ stock performed recently?
Johnson & Johnson [JNJ] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.28. With this latest performance, JNJ shares dropped by -0.10% in over the last four-week period, additionally plugging by 8.36% over the last 6 months – not to mention a rise of 22.02% in the past year of trading.
Johnson & Johnson [JNJ]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Johnson & Johnson [JNJ] shares currently have an operating margin of 24.02% and a Gross Margin at 68.12%. Johnson & Johnson’s Net Margin is presently recorded at 25.01%.
Johnson & Johnson (JNJ) Capital Structure & Debt Analysis
According to recent financial data for Johnson & Johnson. ( JNJ), the Return on Equity (ROE) stands at 30.21%, highlighting impressive shareholder gains. The Return on Assets (ROA) is 12.10%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Johnson & Johnson’s Return on Invested Capital (ROIC) is 19.25%, showcasing its effectiveness in deploying capital for earnings.
Johnson & Johnson (JNJ) Efficiency & Liquidity Metrics
Based on Johnson & Johnson’s (JNJ) latest financial statements, the Debt-to-Equity Ratio is 0.65%, indicating its reliance on debt financing relative to shareholder equity.
Johnson & Johnson (JNJ) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Johnson & Johnson. (JNJ) effectively leverages its workforce, generating an average of $162088.7 per employee. The company’s liquidity position is robust, with a Current Ratio of 1.01% and a Quick Ratio of 0.76%, indicating strong ability to cover short-term liabilities.
Earnings analysis for Johnson & Johnson [JNJ]
With the latest financial reports released by the company, Johnson & Johnson posted 2.42/share EPS, while the average EPS was predicted by analysts to be reported at 2.21/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.21. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for JNJ. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Johnson & Johnson go to 6.61%.
Insider trade positions for Johnson & Johnson [JNJ]
There are presently around $74.37%, or 74.41%% of JNJ stock, in the hands of institutional investors. The top three institutional holders of JNJ stocks are: VANGUARD GROUP INC with ownership of 229.04 million shares, which is approximately 9.5164%. BLACKROCK INC., holding 198.19 million shares of the stock with an approximate value of $$28.97 billion in JNJ stocks shares; and BLACKROCK INC., currently with $$19.45 billion in JNJ stock with ownership which is approximately 5.5298%.
